U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 200

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:88893228
GRCh38:
Chr16:88826820
GALNSS156R, S341R, S347RMucopolysaccharidosis, MPS-IV-ALikely pathogenic
(Oct 26, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr16:88909394
GRCh38:
Chr16:88842986
GALNSMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jan 5, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr16:88909181
GRCh38:
Chr16:88842773
GALNSMucopolysaccharidosis, MPS-IV-AUncertain significance
(Oct 21, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr16:88923255
GRCh38:
Chr16:88856847
GALNS, TRAPPC2LW11RMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr16:88898432
GRCh38:
Chr16:88832024
GALNSW141R, W326R, W332RMucopolysaccharidosis, MPS-IV-AUncertain significance
(May 2, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr16:88904108
GRCh38:
Chr16:88837700
GALNSP163L, P169LMucopolysaccharidosis, MPS-IV-AUncertain significance
(Nov 12, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr16:88923168
GRCh38:
Chr16:88856760
TRAPPC2L, GALNSD40YMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr16:88893161
GRCh38:
Chr16:88826753
GALNSI178T, I363T, I369TMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jun 11, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr16:88908285-88908399
GALNSMucopolysaccharidosis, MPS-IV-AUncertain significance
(May 23, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr16:88923211
GRCh38:
Chr16:88856803
GALNS, TRAPPC2LMucopolysaccharidosis, MPS-IV-ALikely benign
(Mar 21, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr16:88909147
GRCh38:
Chr16:88842739
GALNSN71D, N77DMucopolysaccharidosis, MPS-IV-AUncertain significance
(Apr 12, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr16:88902596
GRCh38:
Chr16:88836188
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 7, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr16:88907509
GRCh38:
Chr16:88841101
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Feb 23, 2020)
criteria provided, single submitter
14.
GRCh37:
Chr16:88902642
GRCh38:
Chr16:88836234
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 20, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr16:88902187
GRCh38:
Chr16:88835779
GALNST241M, T50M, T235MMucopolysaccharidosis, MPS-IV-AUncertain significance
(Mar 10, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr16:88893198
GRCh38:
Chr16:88826790
GALNSA166S, A351S, A357SMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jul 16, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr16:88901751
GRCh38:
Chr16:88835343
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Oct 23, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr16:88904181
GRCh38:
Chr16:88837773
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 13, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr16:88889053
GRCh38:
Chr16:88822645
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 3, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr16:88898514
GRCh38:
Chr16:88832106
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jun 13, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr16:88909253
GRCh38:
Chr16:88842845
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 13, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr16:88908386
GRCh38:
Chr16:88841978
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 13, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr16:88908315
GRCh38:
Chr16:88841907
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 13, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr16:88904078-88904080
GRCh38:
Chr16:88837670-88837672
GALNSN178del, N172delMucopolysaccharidosis, MPS-IV-AUncertain significance
(Dec 8, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr16:88904019
GRCh38:
Chr16:88837611
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Apr 16, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr16:88901633
GRCh38:
Chr16:88835225
GALNSA111T, A296T, A302TMucopolysaccharidosis, MPS-IV-AUncertain significance
(Mar 15, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr16:88908372
GRCh38:
Chr16:88841964
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(May 31, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr16:88901671
GRCh38:
Chr16:88835263
GALNSV98A, V289A, V283AMucopolysaccharidosis, MPS-IV-AUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr16:88923181
GRCh38:
Chr16:88856773
GALNS, TRAPPC2LMucopolysaccharidosis, MPS-IV-ALikely benign
(Mar 30, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr16:88880885
GRCh38:
Chr16:88814477
GALNSP326S, P511S, P517SMucopolysaccharidosis, MPS-IV-AUncertain significance
(May 15, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr16:88891291
GRCh38:
Chr16:88824883
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jan 17, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr16:88893090
GRCh38:
Chr16:88826682
GALNSMucopolysaccharidosis, MPS-IV-ABenign
(Oct 21, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr16:88902633
GRCh38:
Chr16:88836225
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Apr 29, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr16:88909187
GRCh38:
Chr16:88842779
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 29, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr16:88923153
GRCh38:
Chr16:88856745
GALNS, TRAPPC2LMucopolysaccharidosis, MPS-IV-ABenign
(Aug 16, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr16:88904189
GRCh38:
Chr16:88837781
GALNSMucopolysaccharidosis, MPS-IV-AUncertain significance
(Apr 30, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr16:88904065-88904103
GRCh38:
Chr16:88837657-88837695
GALNSMucopolysaccharidosis, MPS-IV-APathogenic
(Apr 16, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr16:88880952
GRCh38:
Chr16:88814544
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 23, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr16:88891174
GRCh38:
Chr16:88824766
GALNSMucopolysaccharidosis, MPS-IV-ALikely pathogenic
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr16:88904111
GRCh38:
Chr16:88837703
GALNSS162Y, S168YMucopolysaccharidosis, MPS-IV-APathogenic
(Aug 23, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr16:88904018
GRCh38:
Chr16:88837610
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Mar 15, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr16:88909185
GRCh38:
Chr16:88842777
GALNSN58S, N64SMucopolysaccharidosis, MPS-IV-AUncertain significance
(Feb 28, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr16:88880929
GRCh38:
Chr16:88814521
GALNSW311S, W502S, W496SMucopolysaccharidosis, MPS-IV-ALikely pathogenic
(Apr 11, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr16:88902137
GRCh38:
Chr16:88835729
GALNSG67R, G252R, G258RMucopolysaccharidosis, MPS-IV-AUncertain significance
(Aug 12, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr16:88891257
GRCh38:
Chr16:88824849
GALNSG202D, G393D, G387DMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jan 17, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr16:88909243
GRCh38:
Chr16:88842835
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Oct 13, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr16:88909145
GRCh38:
Chr16:88842737
GALNSN71K, N77KMucopolysaccharidosis, MPS-IV-AUncertain significance
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr16:88902215-88902216
GRCh38:
Chr16:88835807-88835808
GALNSF41fs, F226fs, F232fsMucopolysaccharidosis, MPS-IV-APathogenic
(Feb 17, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr16:88902130
GRCh38:
Chr16:88835722
GALNSMucopolysaccharidosis, MPS-IV-AUncertain significance
(Aug 6, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr16:88908318
GRCh38:
Chr16:88841910
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jun 14, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr16:88904134
GRCh38:
Chr16:88837726
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Oct 25, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr16:88893262
GRCh38:
Chr16:88826854
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 10, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr16:88909188
GRCh38:
Chr16:88842780
GALNSP57L, P63LMucopolysaccharidosis, MPS-IV-AUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr16:88880885
GRCh38:
Chr16:88814477
GALNSP511A, P517A, P326AMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jan 21, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr16:88893226
GRCh38:
Chr16:88826818
GALNSS156R, S341R, S347RMucopolysaccharidosis, MPS-IV-APathogenic
(Dec 16, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr16:88923147
GRCh38:
Chr16:88856739
TRAPPC2L, GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 17, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr16:88893110
GRCh38:
Chr16:88826702
GALNSR380K, R195K, R386KMucopolysaccharidosis, MPS-IV-AUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr16:88884424
GRCh38:
Chr16:88818016
GALNSW497*, W306*, W491*Mucopolysaccharidosis, MPS-IV-APathogenic
(Oct 3, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr16:88888982
GRCh38:
Chr16:88822574
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Oct 19, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr16:88904017
GRCh38:
Chr16:88837609
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(May 6, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr16:88923240
GRCh38:
Chr16:88856832
TRAPPC2L, GALNSV16LMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jun 22, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr16:88902199
GRCh38:
Chr16:88835791
GALNSA237V, A231V, A46VMucopolysaccharidosis, MPS-IV-AUncertain significance
(Feb 18, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr16:88907408
GRCh38:
Chr16:88841000
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(May 21, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr16:88891251
GRCh38:
Chr16:88824843
GALNST204M, T389M, T395MMucopolysaccharidosis, MPS-IV-AUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr16:88889091
GRCh38:
Chr16:88822683
GALNSV430I, V239I, V424IMucopolysaccharidosis, MPS-IV-AUncertain significance
(Jun 13, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr16:88904146
GRCh38:
Chr16:88837738
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 13, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr16:88908383
GRCh38:
Chr16:88841975
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 6, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr16:88904142
GRCh38:
Chr16:88837734
GALNSMucopolysaccharidosis, MPS-IV-APathogenic/Likely pathogenic
(Sep 2, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr16:88901684
GRCh38:
Chr16:88835276
GALNSD279fs, D285fs, D94fsMucopolysaccharidosis, MPS-IV-ALikely pathogenic
(Dec 24, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr16:88907448
GRCh38:
Chr16:88841040
GALNSP125fs, P131fsMucopolysaccharidosis, MPS-IV-APathogenic
(Jul 30, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr16:88904124
GRCh38:
Chr16:88837716
GALNSE158*, E164*Mucopolysaccharidosis, MPS-IV-APathogenic
(May 22, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr16:88889120
GRCh38:
Chr16:88822712
GALNSMucopolysaccharidosis, MPS-IV-ALikely pathogenic
(May 4, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr16:88884452
GRCh38:
Chr16:88818044
GALNSA297V, A482V, A488VMucopolysaccharidosis, MPS-IV-ALikely pathogenic
(May 9, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr16:88901728
GRCh38:
Chr16:88835320
GALNSS264N, S270N, S79NMucopolysaccharidosis, MPS-IV-ALikely pathogenic
(May 9, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr16:88898499
GRCh38:
Chr16:88832091
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 16, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr16:88907423
GRCh38:
Chr16:88841015
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Mar 18, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr16:88907515
GRCh38:
Chr16:88841107
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Feb 24, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr16:88909255
GRCh38:
Chr16:88842847
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 19, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr16:88923196
GRCh38:
Chr16:88856788
TRAPPC2L, GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jun 13, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr16:88891159
GRCh38:
Chr16:88824751
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 22, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr16:88891240-88891241
GRCh38:
Chr16:88824832-88824833
GALNSA208S, A393S, A399SMucopolysaccharidosis, MPS-IV-ALikely benign
(Jun 27, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr16:88884436
GRCh38:
Chr16:88818028
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Oct 13, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr16:88898528
GRCh38:
Chr16:88832120
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jun 20, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr16:88891158
GRCh38:
Chr16:88824750
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(May 12, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr16:88884536
GRCh38:
Chr16:88818128
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jan 8, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr16:88902228
GRCh38:
Chr16:88835820
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 9, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr16:88884552
GRCh38:
Chr16:88818144
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jul 19, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr16:88884487
GRCh38:
Chr16:88818079
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Nov 1, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr16:88888983
GRCh38:
Chr16:88822575
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Feb 5, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr16:88907383
GRCh38:
Chr16:88840975
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jun 5, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr16:88889032
GRCh38:
Chr16:88822624
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 10, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr16:88898395
GRCh38:
Chr16:88831987
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jul 5, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr16:88904143
GRCh38:
Chr16:88837735
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jul 23, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr16:88909253
GRCh38:
Chr16:88842845
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jun 2, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr16:88893090
GRCh38:
Chr16:88826682
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Aug 5, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr16:88923152
GRCh38:
Chr16:88856744
GALNS, TRAPPC2LMucopolysaccharidosis, MPS-IV-ALikely benign
(Oct 19, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr16:88902597
GRCh38:
Chr16:88836189
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 9, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr16:88893166
GRCh38:
Chr16:88826758
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Dec 2, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr16:88893178
GRCh38:
Chr16:88826770
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Jan 4, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr16:88884487
GRCh38:
Chr16:88818079
GALNSMucopolysaccharidosis, MPS-IV-ALikely benign
(Sep 1, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination